Clinical efficacy: In a randomized Phase II frontline RAS‑mutant mCRC cohort, the 30 mg onvansertib + FOLFIRI + bevacizumab arm produced a confirmed ORR of 72.2% versus ~43% for standard‑of‑care, with ...
The Bureau’s axing of its long-term weather monitoring software Enviromon, first revealed by The Courier-Mail in November, prompted council leaders to warn their communities would be less safe during ...
At OxTS our brand promise is “navigation experts”. Our commitment to our customers is that we will keep innovating until we can help them truly ‘navigate anywhere’ – with or without GNSS. We are ...
About SRx Health Solutions Inc. Better Choice Co., Inc. is an animal health and wellness company. The firm sells dog food, cat food, and treats under the Halo and TruDog brands, which are focused on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results